<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00773201</url>
  </required_header>
  <id_info>
    <org_study_id>P071001</org_study_id>
    <nct_id>NCT00773201</nct_id>
  </id_info>
  <brief_title>Genetic Sources of Variability of the Adaptation of the Ventricular Repolarisation</brief_title>
  <acronym>Generepol</acronym>
  <official_title>Identification of the Genetic Sources of Variability of the Adaptation of the Ventricular Repolarisation at a Pharmacological and Physiological Stimulus in an Apparently Normal Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective is to research for genetic factors involved in the extreme modifications
      of the QT interval of the electrocardiogram in answer to a pharmacological stimulation
      (sotalol) and physiological stimulation in the apparently normal general population.

      The phenotypic characterization, based on the ventricular repolarisation dynamics will be
      used aiming at term of the predictive genetic factors of the acquired long QT syndrome
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study of 1000 apparently healthy subjects which will receive an unique dose of Sotalol and
      will have an effort test on ergonomic bicycle, an auditive stimulation and a taking of DNA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The elongation of the corrected interval QT duration 3 hours after the unique oral taking of an 80 mg dose of Sotalol.</measure>
    <time_frame>3 hours after the taking of Sotalol</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Constitute a biological base and a phenotypic base of resources which will allow to define answer phenotypes to the implemented dynamic tests</measure>
    <time_frame>At the inclusion visit</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Look for associations between these phenotypes of electrocardiographically answer and mutations or polymorphisms.</measure>
    <time_frame>At the inclusion visit</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">997</enrollment>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy subjects</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sotalol 80 mg</intervention_name>
    <description>healthy subjects will receive an unique dose of Sotalol and will have an effort test on ergonomic bicycle, an auditive stimulation and a taking of DNA</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Both sexes

          -  Age between 18 and 60 years

          -  European or North African Origin

          -  Body mass index between 19 and 29 kg / m ²

          -  Obtaining informed and written consent

        Exclusion Criteria:

          -  Asthma

          -  Heart rate &lt; 50 bpm

          -  Systolic blood pressure &lt; 100 mm Hg

          -  Atrioventricular block

          -  Known chronic illness with chronic treatment

          -  Raynaud phenomenon

          -  QT prolonging drug

          -  Family or personal history of the congenital long QT syndrome

          -  QT/QTc Fridericia (QTcf) &gt; 450 ms

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beny Charbit, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Saint Antoine, Assistance Publique - Hopitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre d'investigation clinique; Hôpital Saint Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2008</study_first_submitted>
  <study_first_submitted_qc>October 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2008</study_first_posted>
  <last_update_submitted>July 25, 2012</last_update_submitted>
  <last_update_submitted_qc>July 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Long QT syndrome</keyword>
  <keyword>Cardiac repolarisation</keyword>
  <keyword>Genome-wide association</keyword>
  <keyword>Electrophysiology</keyword>
  <keyword>Drugs/adverse effects</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sotalol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

